Sina Bavari Selected Research

Marburg Virus Disease

11/2020	Remdesivir (GS-5734) Is Efficacious in Cynomolgus Macaques Infected With Marburg Virus.
2/2016	Delayed Time-to-Treatment of an Antisense Morpholino Oligomer Is Effective against Lethal Marburg Virus Infection in Cynomolgus Macaques.
4/2014	Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430.
11/2012	Discovery and early development of AVI-7537 and AVI-7288 for the treatment of Ebola virus and Marburg virus infections.
7/2009	Development and characterization of a mouse model for Marburg hemorrhagic fever.
6/2005	Filovirus-like particles as vaccines and discovery tools.
1/2004	Generation of Marburg virus-like particles by co-expression of glycoprotein and matrix protein.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sina Bavari Research Topics

Disease

86	Infections 01/2022 - 03/2002
24	Ebola Hemorrhagic Fever 01/2021 - 07/2004
14	Filoviridae Infections 01/2018 - 09/2004
12	Anthrax 01/2022 - 03/2005
10	Botulism 01/2021 - 04/2010
10	Virus Diseases (Viral Diseases) 01/2019 - 04/2005
9	Paralysis (Palsy) 01/2017 - 04/2007
8	Fever (Fevers) 01/2018 - 04/2005
7	Marburg Virus Disease 11/2020 - 01/2004
5	Viremia 01/2020 - 05/2008
5	Vesicular Stomatitis 09/2019 - 05/2010
5	Viral Hemorrhagic Fevers (Viral Hemorrhagic Fever) 01/2018 - 09/2010
5	Poisoning 01/2016 - 04/2010
4	Communicable Diseases (Infectious Diseases) 01/2022 - 01/2013
3	Inflammation (Inflammations) 01/2021 - 11/2014
3	Neoplasms (Cancer) 09/2017 - 12/2013
2	COVID-19 01/2021 - 08/2020
2	Zika Virus Infection 01/2018 - 01/2017
2	HIV Infections (HIV Infection) 01/2017 - 05/2010
2	Human Influenza (Influenza) 10/2016 - 01/2016
2	Body Weight (Weight, Body) 02/2016 - 07/2015
2	Tularemia 12/2009 - 05/2007
2	Septic Shock (Toxic Shock Syndrome) 09/2005 - 06/2003
2	Shock 04/2005 - 08/2002
1	Zoonoses 12/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Coronavirus Infections 01/2019
1	Melioidosis 01/2019
1	Uveitis 04/2018
1	Cataract (Cataracts) 04/2018
1	Bacterial Infections (Bacterial Infection) 01/2018
1	Arenaviridae Infections 01/2018

Drug/Important Bio-Agent (IBA)

40	VaccinesIBA 12/2021 - 08/2002
21	Proteins (Proteins, Gene)FDA Link 11/2019 - 07/2004
17	Antiviral Agents (Antivirals)IBA 10/2019 - 07/2009
15	Pharmaceutical PreparationsIBA 11/2017 - 04/2010
13	Botulinum Toxins (Botulinum Toxin)IBA 01/2021 - 04/2007
12	Glycoproteins (Glycoprotein)IBA 01/2018 - 07/2004
9	CytokinesIBA 01/2021 - 08/2002
6	Small Interfering RNA (siRNA)IBA 01/2017 - 05/2010
6	MorpholinosIBA 02/2016 - 01/2006
5	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 07/2006
5	incobotulinumtoxinA FDA Link 01/2021 - 03/2010
4	AntigensIBA 01/2018 - 10/2005
4	Viral ProteinsIBA 10/2016 - 07/2005
4	Metalloproteases (Metalloproteinases)IBA 07/2012 - 01/2010
3	Monoclonal AntibodiesIBA 01/2022 - 10/2005
3	AerosolsIBA 01/2021 - 04/2005
3	Neutralizing AntibodiesIBA 01/2020 - 01/2016
3	Peptides (Polypeptides)IBA 11/2019 - 05/2011
3	Viral RNAIBA 01/2018 - 04/2008
3	AntibodiesIBA 01/2018 - 07/2006
3	SNARE Proteins (SNAREs)IBA 01/2017 - 01/2010
3	NucleoproteinsIBA 02/2016 - 02/2014
3	AVI-7288IBA 02/2016 - 11/2012
3	Biomarkers (Surrogate Marker)IBA 01/2015 - 06/2003
3	anthrax toxin (anthrax lethal factor)IBA 08/2013 - 10/2005
3	Biological Warfare AgentsIBA 06/2011 - 08/2005
3	Biological ProductsIBA 08/2010 - 03/2005
2	remdesivirIBA 01/2021 - 11/2020
2	emvododstatIBA 01/2021 - 08/2020
2	RNA (Ribonucleic Acid)IBA 04/2018 - 01/2016
2	Interferon Type IIBA 01/2018 - 01/2015
2	favipiravirIBA 01/2018 - 01/2018
2	GlucosidasesIBA 01/2018 - 06/2013
2	Ribavirin (Virazole)FDA LinkGeneric 01/2018 - 06/2011
2	Phosphotransferases (Kinase)IBA 01/2017 - 01/2015
2	Peptide Hydrolases (Proteases)FDA Link 10/2016 - 06/2010
2	Adenosine (Adenocard)FDA LinkGeneric 05/2016 - 04/2014
2	galidesivirIBA 05/2016 - 04/2014
2	Antimalarials (Antimalarial Agents)IBA 08/2015 - 05/2014
2	Neurotransmitter Agents (Neurotransmitter)IBA 05/2015 - 01/2011
2	Poly I-CIBA 03/2015 - 02/2014
2	AntioxidantsIBA 01/2014 - 01/2012
2	ClathrinIBA 09/2013 - 05/2010
2	EnzymesIBA 10/2010 - 01/2010
2	Acetylcholine (Acetylcholine Chloride)FDA Link 10/2010 - 01/2010
2	ZincIBA 10/2010 - 01/2010
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 08/2009 - 05/2009
2	Protein Tyrosine PhosphatasesIBA 08/2009 - 05/2009
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 03/2007 - 05/2005
1	obiltoxaximabIBA 01/2022
1	Anthrax Vaccines (Vaccines, Anthrax)IBA 01/2022
1	Immunologic Factors (Immunomodulators)IBA 01/2022
1	raxibacumabIBA 01/2022
1	Doxycycline (Periostat)FDA LinkGeneric 01/2022
1	BiothraxIBA 01/2022
1	Ciprofloxacin (Cipro)FDA LinkGeneric 01/2022
1	Bacterial ToxinsIBA 01/2021
1	CholesterolIBA 11/2019
1	NucleotidesIBA 10/2019
1	nitazoxanide (NTZ)FDA Link 09/2019
1	Blood Proteins (Serum Proteins)IBA 01/2019
1	ProteomeIBA 01/2019
1	Viral Nonstructural ProteinsIBA 01/2019
1	Complement System Proteins (Complement)IBA 01/2019
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2019
1	glucosidase IIBA 01/2018

Therapy/Procedure

45	Therapeutics 01/2022 - 03/2002
1	Euthanasia (Mercy Killing) 01/2021